Stereotactic Radiation Linked to Better Brain Mets Outcomes

Published Date: 23 Feb 2026

Researchers compared outcomes of stereotactic radiation and hippocampal-avoidance whole brain radiation in patients with 5-20 brain metastases.

Read Full News

Todays Updates


Breast Cancer Patients Living Longer Post-Medicaid Expansion


Patients with breast cancer living in states with expanded Medicaid eligibility, have seen survival gains, raising more concerns about the impact of recent changes to the program.

FDA Approves Monthly Dosing of Rybrevant Faspro for NSCLC


The agent, first approved in December for biweekly subcutaneous injection for EGFR-mutated NSCLC, showed similar efficacy and safety when administered monthly.

Cancer and HIV Vaccines Enter the Therapeutic Era


Therapeutic vaccines are advancing in oncology and HIV, with the aim of retraining immune responses to target tumors and persistent viral reservoirs with precision.

Which Salvage Therapy Is Best for Recurrent Prostate Cancer?


Ten-year survival data support salvage focal therapy as an option for patients with localized recurrence after prostate cancer radiotherapy.

Home Screening Appeals to Women Facing Healthcare Barriers


Researchers asked more than 2000 women if they preferred at-home vaginal self-sampling over clinic-based testing to screen for cervical cancer.

PSMA PET: Prostate Cancer Staging Revolution Awaits RCT Data


‘Step by step, little by little, we are learning how to act on this new staging information,’ one investigator says.

Acalabrutinib + Venetoclax Combo Earns FDA Nod for CLL


The all-oral, fixed-duration treatment combination provided better PFS and safety than investigator’s choice of chemoimmunotherapy in the phase 3 AMPLIFY study.

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

What Dolph Lundgren's journey from terminal diagnosis to 'cancer free' can tell us about cancer care

2.

PSMA PET Beats MRI in Prostate Cancer Staging Study

3.

Study finds 1 in 12 patients labeled as having 'benign' results actually had high-risk prostate cancer

4.

New imaging technique identifies glioblastoma patients who would benefit from immunotherapy

5.

The FDA Approves the New Frontline Aggressive ALL Regimen.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot